AMIFOS 500mg Injection Vial

Frequently asked questions

• Onset of action

  The amount of time required for this medicine to show its action is not clinically established.

• Duration of Effect

  The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit-forming tendencies were reported

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Discuss all the risks and benefits with your doctor before receiving this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before receiving this medicine.

• Allergy

  This medicine is not recommended for use if you have a known allergy to AMIFOS 500mg Injection Vial , aminothiol compounds, or any other inactive ingredients present along with it.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Discuss all the risks and benefits with your doctor before receiving this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before receiving this medicine.

• Adequate hydration

  Patients are advised to ensure adequate hydration due to the increased risk of dehydration. Drink an adequate amount of water or liquids to maintain hydration.

• Cutaneous reactions

  This medicine may cause serious cutaneous reactions such as skin rash, lesions, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema, etc. in some patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

• Hypocalcemia

  This medicine may lower the blood calcium levels and hence should be used with extreme caution in patients with hypocalcemia (decreased calcium levels in the blood) due to the risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

• Use in children

  The safety and efficacy of this medicine have not been clinically established in children below 18 years of age.

• Driving or operating machinery

  Use of this medicine may cause dizziness, fatigue, and blurring of vision. Hence, it is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating heavy machinery during treatment with this medicine.

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• May cause sleepiness

• pubchem - Amifostine [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/amifostine [cited 2/6/2021]. 2021